Inventor · Dedham, MA, US

Alex Nivorozhkin

27Patents
5h-index
20Co-inventors
69Inventor score

Filing activity: Jul 18, 2002 → Mar 8, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US11242318B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 32 Active
US10252982B2 Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Chemistry; Metallurgy 9 Active
US9913803B2 Single-layer oral dose of neuro-attenuating ketamine Human Necessities 9 Active
US9285352B2 System and method for detection of a contaminated beverage Emerging Cross-Sectional Technologies 7 Active
US11834410B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 5 Active
US11724985B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 5 Active
US11746088B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 5 Active
US10653629B2 Single layer oral dose of neuro-attenuating ketamine Human Necessities 5 Active
US11958807B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 3 Active
US7078423B2 5-Aryltetrazole compounds, compositions thereof, and uses therefor Chemistry; Metallurgy 3 Expired
US10274475B2 System and method for detection of a contaminated beverage Emerging Cross-Sectional Technologies 2 Active
US7087631B2 Aryltetrazole compounds, and compositions thereof Chemistry; Metallurgy 2 Expired
US11098024B2 Methods and related tools for CBD conversion to THC Emerging Cross-Sectional Technologies 1 Active
US11554100B2 Single-layer oral dose of neuro-attenuating ketamine Human Necessities 0 Active
US12240813B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 0 Active
US9217018B2 HSP70 fusion protein conjugates and uses thereof Chemistry; Metallurgy 0 Active
US9937241B2 Degradation resistant HSP70 formulations and uses thereof Human Necessities 0 Active
US11603348B2 Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Chemistry; Metallurgy 0 Active
US12122741B2 Therapeutic phenethylamine compositions and methods of use Chemistry; Metallurgy 0 Active
US7135491B2 5-Aryltetrazole compounds and uses thereof Chemistry; Metallurgy 0 Expired
US12110272B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 0 Active
US9989509B2 System and method for detection of a contaminated beverage Emerging Cross-Sectional Technologies 0 Active
US11613515B2 Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Chemistry; Metallurgy 0 Active
US12264141B2 Methods and related tools for CBD conversion to THC Emerging Cross-Sectional Technologies 0 Active
US12291499B2 Deuterated tryptamine derivatives and methods of use Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.